UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Reorganising the emergency department to manage the COVID-19 outbreak

International journal of emergency medicine, 2020-06, Vol.13 (1), p.1-11, Article 32

2020

Volltextzugriff (PDF)

Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma

The journal of clinical endocrinology and metabolism, 2018-01, Vol.103 (1), p.213-220

2018

Volltextzugriff (PDF)

Experience of living with COVID-19: personal preparedness and coping mechanism among deployed healthcare workers

Disaster medicine and public health preparedness, 2022-03, Vol.16 (6), p.1-2408

2022

Volltextzugriff (PDF)

Review of Tolvaptan's Pharmacokinetic and Pharmacodynamic Properties and Drug Interactions

Journal of clinical medicine, 2014-11, Vol.3 (4), p.1276-1290

2014

Volltextzugriff (PDF)

PILOT STUDY OF THE RELATIONSHIP OF AMBIENT COPEPTIN TO THE AQUARETIC EFFECTS OF TOLVAPTAN IN PATIENTS WITH HEART FAILURE

Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.A917-A917

2015

Volltextzugriff (PDF)

Unusual genotype of a Uropathogenic Escherichia coli strain assigned to the B2 phylogenetic group

Journal of clinical microbiology, 2011-08, Vol.49 (8), p.3105-3106

2011

Volltextzugriff (PDF)

Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients

Heart failure clinics, 2014-10, Vol.10 (4), p.607

2014

Volltextzugriff (PDF)

A deep learning algorithm to predict coexisting metastatic disease using intraprostatic [F18]DCFPYL PSMA image alone in veterans with prostate cancer

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.25-25

2020

Volltextzugriff (PDF)

Perceptions of Mobile Health Apps and Features to Support Psychosocial Well-being Among Frontline Health Care Workers Involved in the COVID-19 Pandemic Response: Qualitative Study

Journal of medical Internet research, 2021-05, Vol.23 (5), p.e26282-e26282

2021

Volltextzugriff (PDF)

An update on overall survival from a multi-center, open-label, pivotal phase 2b study of AZEDRA® (iobenguane I 131) in patients with iobenguane scan positive locally advanced or metastatic pheochromocytoma/paraganglioma (PPGL)

The Journal of nuclear medicine (1978), 2019-05, Vol.60

2019

Volltextzugriff (PDF)

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase 3, Multicenter Study

Clinical cancer research, 2021-02, Vol.27 (13), p.3674-3682

2021

Volltextzugriff (PDF)

Azedra (iobenguane I 131) in patients with malignant, recurrent and/or unresectable pheochromocytoma or paraganglioma (PPGL): Updated efficacy and safety results from a multi-center, open-label, pivotal phase 2 study

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.4005-4005

2018

Volltextzugriff (PDF)

Long-term survival and safety from a multi-center, open-label, pivotal phase 2 study of iobenguane I 131 in patients (Pts) with unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (PPGL)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.4108-4108

2019

Volltextzugriff (PDF)

A phase III, multicenter study to assess the diagnostic performance and clinical impact of 18 F-DCFPyL PET/CT in men with suspected recurrence of prostate cancer (CONDOR)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.TPS5093-TPS5093

2019

Volltextzugriff (PDF)

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

Clinical cancer research, 2021-07, Vol.27 (13), p.3674-3682

2021

Volltextzugriff (PDF)

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)

The Journal of urology, 2021-07, Vol.206 (1), p.52

2021

Volltextzugriff (PDF)

Results from the OSPREY trial: A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients with PRostate Cancer - Examination of Diagnostic AccuracY

The Journal of nuclear medicine (1978), 2019-05, Vol.60

2019

Volltextzugriff (PDF)

Pooled safety analysis of high-specific-activity I-131 MIBG in iobenguane scan positive cancer patients

Journal of clinical oncology, 2019-02, Vol.37 (4_suppl), p.388-388

2019

Volltextzugriff (PDF)

Diagnostic performance of 18 F-DCFPyL in the OSPREY Trial: A prospective phase 2/3 multicenter study of 18 F-DCFPyL PET/CT imaging in patients (Pts) with known or suspected metastatic prostate cancer (mPC)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.5012-5012

2019

Volltextzugriff (PDF)

Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma

The Journal of nuclear medicine (1978), 2019-05, Vol.60 (5), p.623-630

2019

Volltextzugriff (PDF)

Efficacy and Safety of High-Specific-Activity 131 I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma

Journal of Nuclear Medicine, 2019-05, Vol.60 (5), p.623-630

2019

Volltextzugriff (PDF)

A prospective phase 2/3 multicenter study of 18 F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy (OSPREY)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.TPS5092-TPS5092

2018

Volltextzugriff (PDF)

Perceptions of mHealth applications and features to support psychosocial wellbeing among frontline healthcare workers involved in the COVID-19 pandemic response

Journal of medical Internet research, 2021-04

2021

Volltextzugriff (PDF)

Dynamic emergency department response to the evolving COVID‐19 pandemic: the experience of a tertiary hospital in Singapore

Journal of the American College of Emergency Physicians Open, 2020-12, Vol.1 (6), p.1395-1403

2020

Volltextzugriff (PDF)

Diagnostic Performance of 18 F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

Clinical cancer research, 2021-07, Vol.27 (13), p.3674

2021

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(64)
Berichte
(1)

Sprache

Englisch
(65)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Reorganising the emergency department to manage the COVID-19 outbreak

Phase 1 Study of High-Specific-Activity I-131 MIBG for Metastatic and/or Recurrent Pheochromocytoma or Paraganglioma

Experience of living with COVID-19: personal preparedness and coping mechanism among deployed healthcare workers

Review of Tolvaptan's Pharmacokinetic and Pharmacodynamic Properties and Drug Interactions

PILOT STUDY OF THE RELATIONSHIP OF AMBIENT COPEPTIN TO THE AQUARETIC EFFECTS OF TOLVAPTAN IN PATIENTS WITH HEART FAILURE

Unusual genotype of a Uropathogenic Escherichia coli strain assigned to the B2 phylogenetic group

Potential roles of vaptans in heart failure: experience from clinical trials and considerations for optimizing therapy in target patients

A deep learning algorithm to predict coexisting metastatic disease using intraprostatic [F18]DCFPYL PSMA image alone in veterans with prostate cancer

Perceptions of Mobile Health Apps and Features to Support Psychosocial Well-being Among Frontline Health Care Workers Involved in the COVID-19 Pandemic Response: Qualitative Study

An update on overall survival from a multi-center, open-label, pivotal phase 2b study of AZEDRA® (iobenguane I 131) in patients with iobenguane scan positive locally advanced or metastatic pheochromocytoma/paraganglioma (PPGL)

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase 3, Multicenter Study

Azedra (iobenguane I 131) in patients with malignant, recurrent and/or unresectable pheochromocytoma or paraganglioma (PPGL): Updated efficacy and safety results from a multi-center, open-label, pivotal phase 2 study

Long-term survival and safety from a multi-center, open-label, pivotal phase 2 study of iobenguane I 131 in patients (Pts) with unresectable, locally advanced or metastatic pheochromocytoma or paraganglioma (PPGL)

A phase III, multicenter study to assess the diagnostic performance and clinical impact of 18 F-DCFPyL PET/CT in men with suspected recurrence of prostate cancer (CONDOR)

Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

A Phase 2/3 Prospective Multicenter Study of the Diagnostic Accuracy of Prostate Specific Membrane Antigen PET/CT with 18 F-DCFPyL in Prostate Cancer Patients (OSPREY)

Results from the OSPREY trial: A PrOspective Phase 2/3 Multi-Center Study of 18F-DCFPyL PET/CT Imaging in Patients with PRostate Cancer - Examination of Diagnostic AccuracY

Pooled safety analysis of high-specific-activity I-131 MIBG in iobenguane scan positive cancer patients

Diagnostic performance of 18 F-DCFPyL in the OSPREY Trial: A prospective phase 2/3 multicenter study of 18 F-DCFPyL PET/CT imaging in patients (Pts) with known or suspected metastatic prostate cancer (mPC)

Efficacy and Safety of High-Specific-Activity 131I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma

Efficacy and Safety of High-Specific-Activity 131 I-MIBG Therapy in Patients with Advanced Pheochromocytoma or Paraganglioma

A prospective phase 2/3 multicenter study of 18 F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy (OSPREY)

Perceptions of mHealth applications and features to support psychosocial wellbeing among frontline healthcare workers involved in the COVID-19 pandemic response

Dynamic emergency department response to the evolving COVID‐19 pandemic: the experience of a tertiary hospital in Singapore

Diagnostic Performance of 18 F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study

Suchergebnisse filtern